Repligen Corp logo

Repligen Corp

1
1
NAS:RGEN (USA)   Ordinary Shares
$ 125.85 -0.32 (-0.25%) 03:58 PM EST
503.40
P/B:
3.57
Volume:
379.97K
Avg Vol (2M):
733.57K
Trade In:
Volume:
379.97K
Avg Vol (2M):
733.57K

Business Description

Repligen Corp logo
Repligen Corp
NAICS : 339112 SIC : 3841
ISIN : US7599161095

Share Class Description:

RGEN: Ordinary Shares
Description
Repligen Corp is a global life sciences company. It develops and commercializes innovative bioprocessing technologies and systems that increase efficiencies and flexibility in the process of manufacturing biological drugs. The company's customers include life science companies, global biopharmaceutical companies, and contract manufacturers worldwide. Repligen markets its products globally through a direct commercial organization in the U.S., Europe, and Asia, as well as through strategic partners in select markets. The majority of the company's revenue is generated in North America.
Name Current Vs Industry Vs History
Cash-To-Debt 1.06
Equity-to-Asset 0.69
Debt-to-Equity 0.37
Debt-to-EBITDA 6.94
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 5.69
Distress
Grey
Safe
Beneish M-Score -2.91
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 75.14
9-Day RSI 54.15
14-Day RSI 43.66
6-1 Month Momentum % -21.24
12-1 Month Momentum % -5

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 6.35
Quick Ratio 5.24
Cash Ratio 4.38
Days Inventory 229.87
Days Sales Outstanding 72.09
Days Payable 22.51

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -0.6
Shareholder Yield % -2.18

Financials (Next Earnings Date:2024-08-02 Est.)

RGEN's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:RGEN

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Repligen Corp Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 607.45
EPS (TTM) ($) 0.25
Beta 1.08
Volatility % 43.73
14-Day RSI 43.66
14-Day ATR ($) 4.578496
20-Day SMA ($) 123.0275
12-1 Month Momentum % -5
52-Week Range ($) 110.45 - 211.13
Shares Outstanding (Mil) 55.88

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Repligen Corp Filings

Filing Date Document Date Form
No Filing Data

Repligen Corp Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Repligen Corp Frequently Asked Questions

What is Repligen Corp(RGEN)'s stock price today?
The current price of RGEN is $125.85. The 52 week high of RGEN is $211.13 and 52 week low is $110.45.
When is next earnings date of Repligen Corp(RGEN)?
The next earnings date of Repligen Corp(RGEN) is 2024-08-02 Est..
Does Repligen Corp(RGEN) pay dividends? If so, how much?
Repligen Corp(RGEN) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1